The invention consists of alternative compounds to nitisinone, for the treatment of both AKU and HT1.
Research Institution:
Università degli Studi di Siena
Priorities and sectors:
Life Sciences
The invention consists of alternative compounds to nitisinone, for the treatment of both AKU and HT1.
Università degli Studi di Siena
Life Sciences